Mersana Therapeutics (MRSN) director Alleva received 55,000 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Lawrence M Alleva (director at Mersana Therapeutics Inc., MRSN) reported that they received 55,000 Stock Option (right to buy) on Jun 11, 2024.
- Reporting person
- Alleva Lawrence M
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Grant or award (A) | Stock Option (right to buy)On 55,000 Common Stock1 | +55,000 | - | - | 55,000 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 55,000 direct
Footnotes from the filing
- 1. The award will vest in full on the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continuous service with the Issuer on such vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Alleva report in this MRSN Form 4?
Lawrence M Alleva (director at Mersana Therapeutics Inc., MRSN) reported that they received 55,000 Stock Option (right to buy) on Jun 11, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MRSN
Earlier insider filings at MRSN
- Apr 4, 2024SEC Form 4 filed by Alleva Lawrence M
- Feb 16, 2024SEC Form 4 filed by Mandelia Ashish (Amendment)
- Jan 17, 2024Protopapas Anna converted options into 86,958 shares and sold $79,671 worth of shares (29,399 units at $2.71), increasing direct ownership by 85% to 125,153 units (SEC Form 4)
- Jan 17, 2024Misra Tushar converted options into 8,541 shares and sold $9,097 worth of shares (3,357 units at $2.71), increasing direct ownership by 41% to 17,966 units (SEC Form 4)
- Jan 17, 2024Mandelia Ashish converted options into 12,780 shares and sold $13,618 worth of shares (5,025 units at $2.71), increasing direct ownership by 50% to 23,328 units (SEC Form 4)
Quantisnow market dataNASDAQ
MRSN
Mersana Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2017
Get push alerts for MRSN
Full MRSN profile on Quantisnow Follow MRSN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time